Switching from Tapros ophthalmic solution 0.0015% and Timoptol XE ophthalmic solution 0.5% to Tapcom combination ophthalmic solution.
Sponsors
Nippon Medical School Hospital, Santen Pharmaceutical Co., Ltd.
Conditions
primary open angle glaucoma
Unknown Phase
IOP-lowering effect lasting for 24 hours of Tapcom combination ophthalmic solution switched from Tapros ophthalmic solution 0.0015% and Timoptol XE Ophthalmic Solution 0.5%.
Active, not recruitingJPRN-UMIN000018846
Start: 2015-06-19Target: 20Updated: 2026-06-29
IOP-lowering effect lasting for 24 hours of Tapcom combination ophthalmic solution switched from Tapros ophthalmic solution 0.0015% and Timoptol XE ophthalmic solution 0.5%.
Active, not recruitingJPRN-UMIN000023883
Start: 2016-08-10Target: 20Updated: 2026-06-29